These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 31317205)

  • 1. Stem cells in tissues, organoids, and cancers.
    Wang X
    Cell Mol Life Sci; 2019 Oct; 76(20):4043-4070. PubMed ID: 31317205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential application of cell reprogramming techniques for cancer research.
    Saito S; Lin YC; Nakamura Y; Eckner R; Wuputra K; Kuo KK; Lin CS; Yokoyama KK
    Cell Mol Life Sci; 2019 Jan; 76(1):45-65. PubMed ID: 30283976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche.
    Roulis M; Kaklamanos A; Schernthanner M; Bielecki P; Zhao J; Kaffe E; Frommelt LS; Qu R; Knapp MS; Henriques A; Chalkidi N; Koliaraki V; Jiao J; Brewer JR; Bacher M; Blackburn HN; Zhao X; Breyer RM; Aidinis V; Jain D; Su B; Herschman HR; Kluger Y; Kollias G; Flavell RA
    Nature; 2020 Apr; 580(7804):524-529. PubMed ID: 32322056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.
    Menendez JA; Alarcón T; Corominas-Faja B; Cuyàs E; López-Bonet E; Martin AG; Vellon L
    Cell Cycle; 2014; 13(3):358-70. PubMed ID: 24406535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoids from human tooth showing epithelial stemness phenotype and differentiation potential.
    Hemeryck L; Hermans F; Chappell J; Kobayashi H; Lambrechts D; Lambrichts I; Bronckaers A; Vankelecom H
    Cell Mol Life Sci; 2022 Feb; 79(3):153. PubMed ID: 35217915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover.
    Alexander KL; Serrano CA; Chakraborty A; Nearing M; Council LN; Riquelme A; Garrido M; Bellis SL; Smythies LE; Smith PD
    J Biol Chem; 2020 Oct; 295(41):14153-14163. PubMed ID: 32763973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic codes in stem cells and cancer stem cells.
    Yamada Y; Watanabe A
    Adv Genet; 2010; 70():177-99. PubMed ID: 20920749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic cell reprogramming as a tool for neurodegenerative diseases.
    Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
    Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.
    Fujii M; Shimokawa M; Date S; Takano A; Matano M; Nanki K; Ohta Y; Toshimitsu K; Nakazato Y; Kawasaki K; Uraoka T; Watanabe T; Kanai T; Sato T
    Cell Stem Cell; 2016 Jun; 18(6):827-838. PubMed ID: 27212702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Reprogram Enablement" as an Assay for Identifying Early Oncogenic Pathways by Their Ability to Allow Neoplastic Cells to Reacquire an Epiblast State.
    Kong Y; Gimple RC; McVicar RN; Hodges AP; Yin J; Liu Y; Zhan W; Snyder EY
    Stem Cell Reports; 2020 Sep; 15(3):761-775. PubMed ID: 32795421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell-derived organoids and their application for medical research and patient treatment.
    Bartfeld S; Clevers H
    J Mol Med (Berl); 2017 Jul; 95(7):729-738. PubMed ID: 28391362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.
    Wang Z; Yang C
    Semin Cancer Biol; 2019 Aug; 57():95-104. PubMed ID: 30641125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
    Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of normal and cancer stem-like cell populations in murine lingual epithelial organoids using single-cell RNA sequencing.
    Johansson E; Ueno H
    Sci Rep; 2021 Nov; 11(1):22329. PubMed ID: 34785704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGR5
    Chang TH; Shanti RM; Liang Y; Zeng J; Shi S; Alawi F; Carrasco L; Zhang Q; Le AD
    Cell Death Dis; 2020 May; 11(5):338. PubMed ID: 32382005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of cancer stem cell gene expression.
    Bapat SA
    Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organoid Culture of Human Cancer Stem Cells.
    Shimono Y; Mukohyama J; Isobe T; Johnston DM; Dalerba P; Suzuki A
    Methods Mol Biol; 2019; 1576():23-31. PubMed ID: 27654995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stem cell division theory of cancer.
    López-Lázaro M
    Crit Rev Oncol Hematol; 2018 Mar; 123():95-113. PubMed ID: 29482784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Mechanisms by which EMT Programs Control Stemness.
    Wilson MM; Weinberg RA; Lees JA; Guen VJ
    Trends Cancer; 2020 Sep; 6(9):775-780. PubMed ID: 32312682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.